Leukemia, Acute Lymphoblastic

Oncology
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
Acute Lymphobastic LeukemiaN/A1 trial
Active Trials
NCT02580981Terminated21Est. Oct 2022
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
Erwinia L-asparaginaseN/A1 trial
Active Trials
NCT00590915No Longer Available

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsAcute Lymphobastic Leukemia

Clinical Trials (2)

Total enrollment: 21 patients across 2 trials

NCT00590915Jazz PharmaceuticalsErwinia L-asparaginase

Erwinase Master Treatment Protocol

N/ANo Longer Available
NCT02580981Alliance PharmaceuticalsAcute Lymphobastic Leukemia

Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses

Start: Jul 2016Est. completion: Oct 202221 patients
N/ATerminated

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space